Multicentre prospective study to evaluate effectiveness and safety of gel-forming and hyaluronic-acid containing chewable tablets as add-on treatment in patients with gastroesophageal reflux disease (GERD) symptoms and unsatisfying proton pump inhibitor therapy
Abstract Background Gastroesophageal reflux disease (GERD) is a common disease which in the majority of patients is treated with proton pump inhibitors (PPI). However, up to 45% of the patients remain symptomatic on a standard dose of PPI. This study investigated the effectiveness and safety of an a...
Main Authors: | Manfred Gross, Dennis Neuschwander, Lisa Steffens, Jörn Thomsen, Kristina Röschmann-Doose |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-09-01
|
Series: | BMC Gastroenterology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12876-023-02946-6 |
Similar Items
-
Diagnosis and Treatment of Refractory Gastroesophageal Reflux Disease (GERD)
by: Selfie, et al.
Published: (2015-12-01) -
Relationship between Gastroesophageal Reflux Disease Questionnaire (GERD-Q) Score and Reflux Oesophagitis in Gastroesophageal Reflux Disease (GERD) Suspected Patients in Bandung
by: Dosmer Oloan Simarmata, et al.
Published: (2020-07-01) -
Assessing the Frequency and Risk Factors Associated with Gastroesophageal Reflux Disease (GERD) in Southern Punjab, Pakistan
by: Rasool MF, et al.
Published: (2021-11-01) -
Gastrointestinal symptoms associated with gastroesophageal reflux disease, and their relapses after treatment with proton pump inhibitors: A systematic review
by: Mousalreza Hosseini, et al.
Published: (2017-06-01) -
Management of gastroesophageal reflux disease in adults: a pharmacist’s perspective
by: MacFarlane B
Published: (2018-06-01)